Clinical trials: Adhesive Capsulitis and Frozen Shoulder Syndrome
- Condition Adhesive Capsulitis and Frozen Shoulder Syndrome
- Funder type Industry (pharma, biotech, devices)
Adhesive Capsulitis
Adhesive Capsulitis and Dynamic Splinting
The purpose of this study is to examine the efficacy of dynamic splinting in reducing contracture following diagnosis of adhesive capsulitis.
- Trial name
- NCT01874821
- Testing
- Dynasplint, Standard of Care
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Dynasplint Systems, Inc.
Adhesive Capsulitis, Frozen Shoulder
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
- Trial name
- AC (NCT02006719)
- Testing
- Collagenase Clostridium Histolyticum
- Where
- 46 sites in United States, Australia
- Volunteers
- 322 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
- Trial name
- NCT01483963
- Testing
- AA4500 0.29 mg/1 mL, AA4500 0.58 mg/2 mL, AA4500 0.58 mg/1 mL
- Where
- 15 sites in United States
- Volunteers
- 50 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
Safety and Efficacy of EN3835 in Participants With Frozen Shoulder
This study will evaluate the safety and efficacy of EN3835 for the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
- Trial name
- NCT04496167
- Testing
- EN3835
- Where
- 38 sites in United States
- Volunteers
- 198 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)
This is a long-term follow-up study to evaluate the safety and durability (efficacy) of response to EN3835 compared to placebo in participants who were treated in EN3835-210 or the pivotal Phase 3 parent studies for the treatment…
- Trial name
- NCT04680156
- Where
- 30 sites in United States
- Volunteers
- 120 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company